SWOG S1512

Primary Category:

Treatment Protocols

Disease Category:

Melanoma, Skin

Status:

Open

A Phase II and Pilot Trial of PD-1 Blockade with MK-3475 (Pembrolizumab) in Patients with Resectable or Unresectable Desmoplastic Melanoma (DM)

 

NCT#02775851